96 related articles for article (PubMed ID: 23632111)
1. Response to letter by Wang Q et al. regarding article "Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension".
Carlomagno G; Fazio S
Int J Cardiol; 2013 Oct; 168(3):3122. PubMed ID: 23632111
[No Abstract] [Full Text] [Related]
2. Letter to the Editor in response to the Carlomagno et al. article regarding the serum sST2 and IL-33 levels in patients with PAH.
Wang Q; Wang C
Int J Cardiol; 2013 Oct; 168(3):2920-1. PubMed ID: 23664435
[No Abstract] [Full Text] [Related]
3. Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension.
Carlomagno G; Messalli G; Melillo RM; Stanziola AA; Visciano C; Mercurio V; Imbriaco M; Ghio S; Sofia M; Bonaduce D; Fazio S
Int J Cardiol; 2013 Sep; 168(2):1545-7. PubMed ID: 23290950
[No Abstract] [Full Text] [Related]
4. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure.
Roth GA; Zimmermann M; Lubsczyk BA; Pilz J; Faybik P; Hetz H; Hacker S; Mangold A; Bacher A; Krenn CG; Ankersmit HJ
J Surg Res; 2010 Oct; 163(2):e79-83. PubMed ID: 20638676
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum interleukin-33 and soluble ST2 across early pregnancy, and their association with miscarriage.
Kaitu'u-Lino TJ; Tuohey L; Tong S
J Reprod Immunol; 2012 Sep; 95(1-2):46-9. PubMed ID: 22841163
[TBL] [Abstract][Full Text] [Related]
6. Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.
Lin CY; Pfluger CM; Henderson RD; McCombe PA
J Neuroimmunol; 2012 Aug; 249(1-2):93-5. PubMed ID: 22633272
[TBL] [Abstract][Full Text] [Related]
7. High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection.
Miyagaki T; Sugaya M; Yokobayashi H; Kato T; Ohmatsu H; Fujita H; Saeki H; Kikuchi Y; Tamaki T; Sato S
J Invest Dermatol; 2011 Mar; 131(3):794-6. PubMed ID: 21150924
[No Abstract] [Full Text] [Related]
8. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.
Secemsky EA; Scherzer R; Nitta E; Wu AH; Lange DC; Deeks SG; Martin JN; Snider J; Ganz P; Hsue PY
JACC Heart Fail; 2015 Aug; 3(8):591-9. PubMed ID: 26164679
[TBL] [Abstract][Full Text] [Related]
9. Are soluble ST2 levels in the picogram or nanogram range in serum of healthy subjects/disease patients?
Saluja R
J Korean Med Sci; 2014 Jan; 29(1):153. PubMed ID: 24431922
[No Abstract] [Full Text] [Related]
10. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
[TBL] [Abstract][Full Text] [Related]
11. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
Ishikawa S; Shimizu M; Ueno K; Sugimoto N; Yachie A
Cytokine; 2013 May; 62(2):272-7. PubMed ID: 23561929
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis.
Li GX; Wang S; Duan ZH; Zeng Z; Pan FM
Scand J Rheumatol; 2013; 42(3):226-31. PubMed ID: 23409750
[TBL] [Abstract][Full Text] [Related]
13. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
[TBL] [Abstract][Full Text] [Related]
14. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
15. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.
Guerrero CD; Arrieta AF; Ramirez ND; Rodríguez LS; Vega R; Bosch I; Rodríguez JA; Narváez CF; Salgado DM
Cytokine; 2013 Mar; 61(3):766-71. PubMed ID: 23357301
[TBL] [Abstract][Full Text] [Related]
16. Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity.
Baumann R; Rabaszowski M; Stenin I; Tilgner L; Gaertner-Akerboom M; Scheckenbach K; Wiltfang J; Chaker A; Schipper J; Wagenmann M
Clin Exp Allergy; 2013 Oct; 43(10):1134-43. PubMed ID: 24074331
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
[TBL] [Abstract][Full Text] [Related]
18. Novel serum biomarkers in pulmonary arterial hypertension.
McGlinchey N; Johnson MK
Biomark Med; 2014; 8(8):1001-11. PubMed ID: 25343672
[TBL] [Abstract][Full Text] [Related]
19. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
20. uPAR, IL-33, and ST2 values as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes.
Cekmez Y; Cekmez F; Ozkaya E; Pirgon O; Yılmaz Z; Yılmaz EA; Kaya G; Süer N; Küçüközkan T
J Interferon Cytokine Res; 2013 Dec; 33(12):778-82. PubMed ID: 24304137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
